GeneDx (WGS) CFO Kevin Feeley Sells Shares to Cover Taxes

What Happened Kevin Feeley, CFO of GeneDx Holdings Corp. (WGS), had RSUs settle (7,197 shares converted at $0.00) on 2026-09-16 and completed multiple open-market sales of 3,728 shares that same day. The sales generated aggregate proceeds of approximately $363,892 (individual weighted-average sale prices reported: $94.26, $95.41, $96.90, $98.27, $99.00). These transactions were sell-to-cover transactions to satisfy tax withholding tied to the RSU settlement, not discretionary stock sells.

Key Details

• Transaction date: 2026-09-16; Form 4 filed 2026-09-18 (filed within the typical two-business-day window).
• RSU settlement: 7,197 RSUs converted to shares at $0.00 (no cash exercise).
• Shares sold: 3,728 shares in multiple tranches for total proceeds ≈ $363,892.
• Reported weighted-average sale prices and ranges: $94.26 (range $94.23–$94.855), $95.41 (range $95.29–$95.52), $96.90 (range $96.445–$97.40), $98.27 (range $97.565–$98.535), $99.00 (range $98.60–$99.305).
• Holdings after transaction: 44,945 shares of Class A Common Stock beneficially owned; additionally holds RSUs representing rights to up to 71,667 shares and options to purchase up to 25,906 shares (per footnote).
• Notable footnotes: sales were to satisfy tax withholding (sell-to-cover). RSUs represent contingent rights to one share upon settlement. Vesting schedule example: 6.25% of the total award vests quarterly (footnote F9).
• Filing timeliness: filed within two business days of the transaction date (appears timely).

Context This was a routine tax-withholding sell-to-cover following RSU settlement (a common, non-discretionary insider action). For clarity: the RSUs converted to shares for no consideration (not an option purchase), and a portion of the resulting shares were sold immediately to cover taxes. Such transactions typically reflect compensation settlement mechanics rather than a personal decision to reduce an insider’s exposure.